IONS - Ionis Pharmaceuticals Inc
IEX Last Trade
47.67
-2.230 -4.678%
Share volume: 2,110,439
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$49.90
-2.23
-4.47%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-02-22 | 2023-05-03 | 2023-08-09 | 2023-11-02 | 2024-02-21 | 2024-05-07 | 2024-08-01 | |
| Total revenue | 159.767 M | 151.890 M | 130.524 M | 188.411 M | 144.207 M | 324.505 M | 119.497 M | 225.250 M | |
| Cost of revenue | 1.515 M | 3.686 M | 1.343 M | 2.537 M | 2.191 M | 3.062 M | 2.151 M | 4.164 M | |
| Gross profit | 158.252 M | 148.204 M | 129.181 M | 185.874 M | 142.016 M | 321.443 M | 117.346 M | 221.086 M | |
| -6.35% | -12.84% | 43.89% | -23.60% | 126.34% | -63.49% | 88.41% | |||
| Operating expenses | 217.406 M | 356.223 M | 243.329 M | 276.069 M | 285.281 M | 327.565 M | 266.859 M | 287.177 M | |
| Selling general and admin | 34.416 M | 47.950 M | 45.516 M | 46.142 M | 69.951 M | 71.010 M | 52.644 M | 65.113 M | |
| Research and development | 182.990 M | 308.273 M | 197.813 M | 229.927 M | 215.330 M | 256.555 M | 214.215 M | 222.064 M | |
| Total expenses | 218.921 M | 359.909 M | 244.672 M | 278.606 M | 287.472 M | 330.627 M | 269.010 M | 291.341 M | |
| 64.40% | -32.02% | 13.87% | 3.18% | 15.01% | -18.64% | 8.30% | |||
| Operating income | -59.154 M | -208.019 M | -114.148 M | -90.195 M | -143.265 M | -6.122 M | -149.513 M | -66.091 M | |
| Ebit | -59.154 M | -208.019 M | -114.148 M | -90.195 M | -143.265 M | -6.122 M | -149.513 M | -66.091 M | |
| Pretax income | -46.709 M | -44.330 M | -112.943 M | -77.448 M | -140.808 M | -2.766 M | -142.728 M | -66.201 M | |
| -5.09% | 154.78% | -31.43% | 81.81% | -98.04% | 5,060.09% | -53.62% | |||
| Income tax | 283.000 K | 8.100 M | 11.380 M | 7.842 M | 6.602 M | 6.497 M | 75.000 K | 64.000 K | |
| Net income basic | -46.992 M | -52.430 M | -124.323 M | -85.290 M | -147.410 M | -9.263 M | -142.803 M | -66.265 M | |
| -11.57% | -137.12% | 31.40% | -72.83% | 93.72% | -1,441.65% | 53.60% | |||
| Net income | -46.992 M | -52.430 M | -124.323 M | -85.290 M | -147.410 M | -9.263 M | -142.803 M | -66.265 M | |
| -11.57% | -137.12% | 31.40% | -72.83% | 93.72% | -1,441.65% | 53.60% |